share_log

中國中藥：聯合公告 就(1)要約人根據公司條例第673條通過計劃安排的方式將 中國中藥控股有限公司私有化之附先決條件之建議 及 (2)建議撤銷中國中藥控股有限公司的上市地位 延長寄發計劃文件的時間

TRAD CHI MED: JOINT ANNOUNCEMENT EXTENSION OF TIME FOR DESPATCH OF THE SCHEME DOCUMENT IN RELATION TO (1) PRE-CONDITIONAL PROPOSAL TO PRIVATISE CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED BY THE OFFEROR BY WAY OF A SCHEME OF ARRANGEMENT UNDER S

香港交易所 ·  Mar 11 08:10
Summary by Moomoo AI
國藥集團共裕有限公司（「要約人」）計劃通過計劃安排方式將中國中藥控股有限公司（「本公司」）私有化，並撤銷其上市地位。本公司於2024年2月21日發布聯合公告，提出私有化建議，並原定於2024年3月13日或之前寄發計劃文件給股東。然而，由於需要更多時間滿足私有化的先決條件，要約人已獲執行人員同意將寄發計劃文件的最後日期延長至2024年10月25日或達成所有先決條件後七日之日期，以較早者為準。本公司將會就滿足先決條件及寄發計劃文件刊發進一步公告。股東及潛在投資者應注意，私有化建議須待先決條件及條件獲達成或豁免後方可實施，並非必然會生效。本公司董事會主席陳映龍於2024年3月11日發出警告，提醒股東及潛在投資者在買賣股份時應審慎行事。
國藥集團共裕有限公司（「要約人」）計劃通過計劃安排方式將中國中藥控股有限公司（「本公司」）私有化，並撤銷其上市地位。本公司於2024年2月21日發布聯合公告，提出私有化建議，並原定於2024年3月13日或之前寄發計劃文件給股東。然而，由於需要更多時間滿足私有化的先決條件，要約人已獲執行人員同意將寄發計劃文件的最後日期延長至2024年10月25日或達成所有先決條件後七日之日期，以較早者為準。本公司將會就滿足先決條件及寄發計劃文件刊發進一步公告。股東及潛在投資者應注意，私有化建議須待先決條件及條件獲達成或豁免後方可實施，並非必然會生效。本公司董事會主席陳映龍於2024年3月11日發出警告，提醒股東及潛在投資者在買賣股份時應審慎行事。
Kongyu Yue Co., Ltd. (the “Contracting Party”) plans to privatize China China Pharmaceutical Holdings Limited (the “Company”) by means of a planned arrangement and withdraw its listed status. THE COMPANY ISSUED A JOINT ANNOUNCEMENT ON 21 FEBRUARY 2024 PROPOSING PRIVATISATION AND ORIGINALLY SCHEDULED TO SEND THE PLAN DOCUMENT TO SHAREHOLDERS ON OR BEFORE 13 MARCH 2024. However, due to the need for more time to meet the privatization prerequisites, the Contracting Party has agreed to extend the deadline for sending the plan documents to 25 October 2024, or seven days after all the prerequisites have been met, whichever is the earlier. The Company will make further announcements regarding the fulfilment of the prerequisites and delivery plan documents. Shareholders and potential investors should be aware that the privatisation proposal is subject to the fulfilment of preconditions and conditions or exemptions and may not necessarily take effect. The Chairman of the Board of Directors of the Company issued a warning on 11 March 2024 reminding shareholders and potential investors to exercise caution when buying and selling shares.
Kongyu Yue Co., Ltd. (the “Contracting Party”) plans to privatize China China Pharmaceutical Holdings Limited (the “Company”) by means of a planned arrangement and withdraw its listed status. THE COMPANY ISSUED A JOINT ANNOUNCEMENT ON 21 FEBRUARY 2024 PROPOSING PRIVATISATION AND ORIGINALLY SCHEDULED TO SEND THE PLAN DOCUMENT TO SHAREHOLDERS ON OR BEFORE 13 MARCH 2024. However, due to the need for more time to meet the privatization prerequisites, the Contracting Party has agreed to extend the deadline for sending the plan documents to 25 October 2024, or seven days after all the prerequisites have been met, whichever is the earlier. The Company will make further announcements regarding the fulfilment of the prerequisites and delivery plan documents. Shareholders and potential investors should be aware that the privatisation proposal is subject to the fulfilment of preconditions and conditions or exemptions and may not necessarily take effect. The Chairman of the Board of Directors of the Company issued a warning on 11 March 2024 reminding shareholders and potential investors to exercise caution when buying and selling shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more